We applied the propensity score analysis to match each CN-AML patient with high and low HIP1 in our cohort, matching was based on age, WBC, cytogenetic group and genes of FLT3-ITD, NPM1, CEBPA, DNMT3A mutations which might affect the microRNA expression (Table S6). This evidence concerns the gene CEBPA and acute myeloid leukemia.